PA8629201A1 - Polimorfo cristalino de acetato de bazedoxifeno - Google Patents
Polimorfo cristalino de acetato de bazedoxifenoInfo
- Publication number
- PA8629201A1 PA8629201A1 PA20058629201A PA8629201A PA8629201A1 PA 8629201 A1 PA8629201 A1 PA 8629201A1 PA 20058629201 A PA20058629201 A PA 20058629201A PA 8629201 A PA8629201 A PA 8629201A PA 8629201 A1 PA8629201 A1 PA 8629201A1
- Authority
- PA
- Panama
- Prior art keywords
- crystal polymorph
- acetate crystal
- bazedoxifen acetate
- bazedoxifen
- same
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/12—Radicals substituted by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/32—Antioestrogens
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Physical Education & Sports Medicine (AREA)
- Reproductive Health (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Gynecology & Obstetrics (AREA)
- Hospice & Palliative Care (AREA)
- Hematology (AREA)
- Dermatology (AREA)
- Psychiatry (AREA)
- Pregnancy & Childbirth (AREA)
- Obesity (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Indole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
LA PRESENTE INVENCION SE DIRIGE A UN POLIMORFO CRISTALINO DE ACETATO DE BAZEDOXIFENO, LAS COMPOSICIONES QUE CONTIENEN EL MISMO, LAS PREPARACIONES DEL MISMO, Y USOS DEL MISMO.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US56058404P | 2004-04-07 | 2004-04-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
PA8629201A1 true PA8629201A1 (es) | 2005-11-25 |
Family
ID=34965585
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PA20058629201A PA8629201A1 (es) | 2004-04-07 | 2005-04-06 | Polimorfo cristalino de acetato de bazedoxifeno |
Country Status (20)
Country | Link |
---|---|
US (1) | US7683052B2 (es) |
EP (1) | EP1732889A1 (es) |
JP (2) | JP2007532548A (es) |
KR (1) | KR20070004815A (es) |
CN (1) | CN1938271A (es) |
AR (1) | AR048683A1 (es) |
AU (1) | AU2005233114A1 (es) |
BR (1) | BRPI0509257A (es) |
CA (1) | CA2561296A1 (es) |
EC (1) | ECSP066910A (es) |
GT (1) | GT200500080A (es) |
IL (1) | IL178101A0 (es) |
NO (1) | NO20065046L (es) |
PA (1) | PA8629201A1 (es) |
PE (1) | PE20060173A1 (es) |
RU (1) | RU2006132352A (es) |
TW (1) | TW200536845A (es) |
UA (1) | UA86055C2 (es) |
WO (1) | WO2005100314A1 (es) |
ZA (1) | ZA200608361B (es) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR054806A1 (es) * | 2005-06-29 | 2007-07-18 | Wyeth Corp | Formulaciones de estrogenos conjugados y bazedoxifeno |
CA2620174A1 (en) * | 2005-08-24 | 2007-03-01 | Wyeth | Bazedoxifene acetate formulations and manufacturing process thereof |
PE20090100A1 (es) * | 2007-03-30 | 2009-02-26 | Wyeth Corp | Metodos de separacion y deteccion de acetato de bacedoxifeno en composiciones farmaceuticas |
CZ302358B6 (cs) * | 2007-07-25 | 2011-03-30 | Zentiva, A. S. | Nové soli bazedoxifenu |
BRPI0908797A2 (pt) * | 2008-02-11 | 2015-07-21 | Wyeth Llc | Métodos para preparar a forma polimórfica a de acetato de bazedoxifeno |
US20100016290A1 (en) * | 2008-02-11 | 2010-01-21 | Livius Cotarca | Amorphous polymorph of bazedoxifene acetate |
ITMI20091109A1 (it) * | 2009-06-23 | 2010-12-24 | Wyeth Corp | Forma polimorfa d di bazedoxifene acetato e metodi per la sua preparazione |
WO2011056532A2 (en) | 2009-10-27 | 2011-05-12 | Wyeth Llc | Bazedoxifene formulations with antioxidants |
EP2407467A1 (de) | 2010-07-14 | 2012-01-18 | Sandoz Ag | Kristalline Verbindung von 1-[4-(2-azepan-1-yl-ethoxy)-benzyl]-2-(4-hydroxyphenyl)-3-methyl-1H-indol-5-ol und Milchsäure |
WO2012007453A1 (en) | 2010-07-14 | 2012-01-19 | Sandoz Ag | Crystalline compound of 1-[4-(2-azepan-1-ylethoxy)benzyl]-2-(4-hydroxyphenyl)-3-methyl-1h-indol-5-ol |
US9212172B2 (en) | 2010-09-14 | 2015-12-15 | Dr. Reddy's Laboratories Limited | Preparation of crystalline bazedoxifene and its salts |
EP2471770A1 (en) | 2010-12-28 | 2012-07-04 | Sandoz Ag | Method of preparing polymorphic pure form A of bazedoxifene acetate |
CN103864664A (zh) * | 2012-12-18 | 2014-06-18 | 江苏柯菲平医药有限公司 | 巴多昔芬乙酸盐新晶型及其制备方法 |
US9751835B2 (en) | 2013-05-15 | 2017-09-05 | Indiana University Research And Technology Corporation | Processes and intermediates for preparing indole pharmaceuticals |
CN103864665B (zh) * | 2014-03-04 | 2016-03-02 | 苏州特瑞药业有限公司 | 醋酸巴多昔芬的制备方法 |
CN104030963A (zh) * | 2014-06-30 | 2014-09-10 | 四川大学 | 一种巴多昔芬醋酸盐晶型a的制备方法 |
CN111004165A (zh) * | 2019-12-03 | 2020-04-14 | 南京正济医药研究有限公司 | 一种醋酸巴多昔芬晶型a的制备方法 |
US11246874B1 (en) | 2021-04-20 | 2022-02-15 | Oxygen Biotech LLC | Treatment of COVID-19 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW397821B (en) | 1996-04-19 | 2000-07-11 | American Home Produits Corp | 3-[4-(2-phenyl-indole-1-ylmethyl)-phenyl]-acrylamides and 2-phenyl-1-[4-(amino-1-yl-alk-1-ynyl)-benzyl]-1H-indol-5-ol as well as pharmaceutical compositions of estrogenic agents thereof |
US5998402A (en) * | 1996-04-19 | 1999-12-07 | American Home Products Corporation | 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents |
US5880137A (en) * | 1996-04-19 | 1999-03-09 | American Home Products Corporation | 2-phenyl-1- 4-(amino-1-yl-alk-1-ynyl)-benzyl!-1H-indol-5-ols as estrogenic agents |
US5780497A (en) * | 1996-04-19 | 1998-07-14 | American Home Products Corporation | 2-phenyl-1- 4-(amino-1-yl-alk-1-ynyl)-benzyl!-1H-indol-5-ols as estrogenic agents |
DE69707189T2 (de) | 1996-04-19 | 2002-06-20 | American Home Prod | Östrogene Verbindungen |
IL135343A0 (en) * | 1997-10-15 | 2001-05-20 | American Home Prod | Novel aryloxy-alkyl-dialkylamines |
US6005102A (en) * | 1997-10-15 | 1999-12-21 | American Home Products Corporation | Aryloxy-alkyl-dialkylamines |
US6479535B1 (en) * | 1998-05-15 | 2002-11-12 | Wyeth | 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole and estrogen formulations |
AR029538A1 (es) * | 2000-07-06 | 2003-07-02 | Wyeth Corp | Composiciones farmaceuticas de agentes estrogenicos |
EP1336602A1 (en) | 2002-02-13 | 2003-08-20 | Giovanni Scaramuzzino | Nitrate prodrugs able to release nitric oxide in a controlled and selective way and their use for prevention and treatment of inflammatory, ischemic and proliferative diseases |
EP1531806A4 (en) * | 2002-06-25 | 2005-09-21 | Wyeth Corp | USE OF THIO-OXINDOLE DERIVATIVES IN THE TREATMENT OF HORMONE-RELATED DISEASES |
KR20060135866A (ko) | 2004-04-07 | 2006-12-29 | 와이어쓰 | 바제독시펜 아세테이트의 결정질 다형체 |
-
2005
- 2005-04-06 PE PE2005000385A patent/PE20060173A1/es not_active Application Discontinuation
- 2005-04-06 EP EP05735042A patent/EP1732889A1/en not_active Withdrawn
- 2005-04-06 PA PA20058629201A patent/PA8629201A1/es unknown
- 2005-04-06 CA CA002561296A patent/CA2561296A1/en not_active Abandoned
- 2005-04-06 KR KR1020067020645A patent/KR20070004815A/ko not_active Application Discontinuation
- 2005-04-06 BR BRPI0509257-4A patent/BRPI0509257A/pt not_active IP Right Cessation
- 2005-04-06 CN CNA2005800103454A patent/CN1938271A/zh not_active Withdrawn
- 2005-04-06 RU RU2006132352/04A patent/RU2006132352A/ru not_active Application Discontinuation
- 2005-04-06 AU AU2005233114A patent/AU2005233114A1/en not_active Withdrawn
- 2005-04-06 AR ARP050101366A patent/AR048683A1/es unknown
- 2005-04-06 TW TW094110849A patent/TW200536845A/zh unknown
- 2005-04-06 GT GT200500080A patent/GT200500080A/es unknown
- 2005-04-06 US US11/100,998 patent/US7683052B2/en active Active
- 2005-04-06 JP JP2007507417A patent/JP2007532548A/ja not_active Abandoned
- 2005-04-06 UA UAA200610608A patent/UA86055C2/ru unknown
- 2005-04-06 WO PCT/US2005/011423 patent/WO2005100314A1/en active Application Filing
-
2006
- 2006-09-14 IL IL178101A patent/IL178101A0/en unknown
- 2006-10-06 EC EC2006006910A patent/ECSP066910A/es unknown
- 2006-10-06 ZA ZA200608361A patent/ZA200608361B/xx unknown
- 2006-11-02 NO NO20065046A patent/NO20065046L/no not_active Application Discontinuation
-
2008
- 2008-06-30 JP JP2008171116A patent/JP2009007361A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
AU2005233114A1 (en) | 2005-10-27 |
TW200536845A (en) | 2005-11-16 |
IL178101A0 (en) | 2006-12-31 |
EP1732889A1 (en) | 2006-12-20 |
PE20060173A1 (es) | 2006-04-12 |
UA86055C2 (ru) | 2009-03-25 |
GT200500080A (es) | 2005-10-31 |
US20050250762A1 (en) | 2005-11-10 |
BRPI0509257A (pt) | 2007-09-11 |
ECSP066910A (es) | 2006-12-20 |
CA2561296A1 (en) | 2005-10-27 |
WO2005100314A1 (en) | 2005-10-27 |
US7683052B2 (en) | 2010-03-23 |
CN1938271A (zh) | 2007-03-28 |
JP2009007361A (ja) | 2009-01-15 |
ZA200608361B (en) | 2010-03-31 |
KR20070004815A (ko) | 2007-01-09 |
AR048683A1 (es) | 2006-05-17 |
JP2007532548A (ja) | 2007-11-15 |
NO20065046L (no) | 2006-11-06 |
RU2006132352A (ru) | 2008-05-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PA8629201A1 (es) | Polimorfo cristalino de acetato de bazedoxifeno | |
CR8615A (es) | Polimorfo cristalino de un acetato de bazedoxifeno | |
PA8629301A1 (es) | Formulaciones de acetato de bezedoxifeno | |
GT200600383A (es) | Formulaciones de acetato de bazedoxifeno | |
CR10420A (es) | Derivados biciclicos como inhibibidores de cetp | |
CR9223A (es) | 18-metil-19-nor-17-pregn-4-en-21, 17-carbolactonas,asi como preparaciones farmaceuticas que las contienen | |
PA8632701A1 (es) | Compuestos terapeuticos | |
CR10149A (es) | Agentes citotóxicos que comprenden nuevos derivados de tomaimicina y su uso terapéutico | |
AR047529A1 (es) | Compuestos de quinolina sustituidos | |
UY30578A1 (es) | Nuevos derivados de 2,4??- y 3, 4??-bipiridina sustituidos, procedimientos para su preparacion, medicamentos conteniéndolos y aplicaciones | |
UY29002A1 (es) | Nuevos derivados de hidantoína, procesos parasu preparación, composiciones farmacéuticas que los contienen y su uso en terapia | |
CR8246A (es) | Forma cristalina gamma-d del clorhidrato de ivabradina, su procedimiento de preparacion y composiciones farmaceuticas que las contienen | |
CR10192A (es) | Compuestos de amido y su uso como productos farmaceuticos | |
PE20090362A1 (es) | Derivados de piperidina/piperazina como moduladores de dgat | |
UY30758A1 (es) | Formas cristalinas del acido (3s)-3-[n-(n'-(-terc-butilfenil)oxamil)alaninil]amino-5-(2',3',5',6'-tetrafluorofenoxi)-4-oxopentanoico, composiciones farmacéuticas conteniéndolas y aplicaciones. | |
GT200500130A (es) | Forma cristalina alfa del ranelato de estroncio, procedimiento para su preparacion y composiciones farmaceuticas que la contienen | |
PA8572201A1 (es) | Inhibidores de metaloproteinasa de triaril-oxi-aril-espiro-pirimidina-2,4,6-triona | |
ECSP055527A (es) | Composiciones de fórmula infantil que contienen luteína y zeaxantina | |
PA8604201A1 (es) | Derivados de 2-amino-piridina utiles para el tratamiento de enfermedades | |
PA8627001A1 (es) | Compuestos para el tratamiento de enfermedades | |
HN2008001393A (es) | Derivados de 1,2,4,5- tetrahidro -3h- benzazepinas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen | |
CR10060A (es) | 3-aminociclopentanocarboxamidas como moduladores de receptores de quimioquinas | |
HN2010000330A (es) | DERIVADOS DE INDOL-2-ONA DISUSTITUIDOS EN 3 y SU PREPARACION | |
PA8603001A1 (es) | Compuestos utiles para el tratamiento de enfermedades | |
PA8661701A1 (es) | Tiazolidinonas, su preparacion y su uso como medicamento |